Policy / Pricing

Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling

BioSpace

As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S.

Policy / Pricing Read full story

pharminent April 2, 2026 (Last updated: April 2, 2026)

BioSpace

As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S.

Policy / Pricing Read full story